There is no FDA-approved testosterone product for women in the United States, so all female use involves either a fractional dose of a male product or a compounded preparation.

The one indication with real consensus-level support is low sexual desire, hypoactive sexual desire dysfunction, in postmenopausal women, using female-appropriate doses, typically about one-tenth of a male dose. Benefits beyond sexual desire, like cognition, mood, energy, muscle, or bone, are not established; the consensus statement behind this is explicit that the evidence is insufficient for those uses. Because testosterone is the molecule with the strongest case for needing compounding, there's simply no approved alternative, it's also the molecule with the clearest documented evidence of compounding quality problems: a laboratory study found roughly half of compounded testosterone samples were off by more than 20% from the prescribed dose.

What to know about this answer

This is the clearest example in the whole topic of a genuine, defensible pro-compounding position sitting right next to the strongest documented evidence that compounding can fail badly, because both are about the same molecule.

What the research shows, and which source each finding rests on

The only indication with consensus-level support for testosterone therapy in women is hypoactive sexual desire dysfunction in postmenopausal women, using female-physiological doses, typically about one-tenth of a male dose; the consensus statement explicitly states evidence is insufficient for other claimed benefits like cognition, mood, energy, muscle, or bone

A[1]

There is no FDA-approved testosterone product for women in the United States, so all female use involves either fractional dosing of a male product or a compounded preparation

A[1]

In a laboratory study of ten compounding pharmacies given an identical testosterone prescription, only 50% of first-batch and 30% of second-batch samples were within plus-or-minus 20% of the prescribed dose, with one pharmacy delivering virtually no active testosterone (0.7% and 3.6% recovery), while commercial FDA-approved comparison products were consistently accurate

D[2]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Compounded testosterone is a reasonable, even preferred, choice for women

At least one mainstream clinician in the field, focused specifically on testosterone

Because there is no FDA-approved female testosterone product, this fits squarely within the recognized exception for a dosage form not commercially available; a stated preference for compounded testosterone cream is based on easier dosing and lower cost, a defensible clinical position given the total absence of an approved alternative.

A[1]

The molecule with the strongest case for compounding also has the clearest evidence of compounding failure

The direct laboratory testing data

The same laboratory study that found large dose-accuracy problems across compounding pharmacies was specifically testing testosterone, meaning the exact situation where compounding is most defensible, no approved alternative exists, is also the one with the best-documented proof that a compounded product's actual dose can be wildly different from what was prescribed, including one sample with almost no active hormone at all.

D[2]

What would settle it: Development and FDA approval of a female-dosed testosterone product would resolve the underlying access gap; in its absence, routine independent potency testing of compounded testosterone products would at least address the dose-accuracy problem.

What is really going on here

  1. Am I being offered testosterone for low sexual desire specifically, the one indication with consensus support, or for something else like energy, mood, or muscle, where evidence is insufficient?
  2. Is my testosterone dose female-appropriate, roughly one-tenth of a male dose, not just a fractionally adjusted male product without real verification?
  3. If I'm on compounded testosterone, has that specific pharmacy's product been independently tested for dose accuracy?
  4. Am I on a testosterone pellet, and if so, do I understand that dosing cannot be adjusted once it's placed?

Questions for your doctor

  1. What specific symptom are we treating with testosterone, and is that the indication with actual consensus support?
  2. What dose and route are you recommending, and how does that compare with an appropriate female physiological dose?
  3. If this is a compounded product, how is dose accuracy being verified?
  4. What would we monitor, and how often, to make sure my levels stay in a safe range?
  5. Are there non-testosterone options I should consider first for what I'm trying to address?

Questions with no answer yet

Is the absence of trial evidence for testosterone benefits beyond libido, such as cognition, mood, energy, muscle, or bone, a sign those benefits do not exist, or a consequence of the fact that no sponsor has ever funded an adequately powered trial with a non-sexual primary endpoint?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: Two commercial testosterone products for women failed or were withdrawn on grounds tied to a sexual indication, and no sponsor has since brought a female testosterone product to market in the US; the consensus statement that says the evidence is insufficient for non-sexual benefits also explicitly calls for the adequately powered randomized trials that would settle the question, and testosterone's status as a controlled substance in the US adds cost and friction that no other menopausal hormone product carries.

What would test it: A publicly funded, adequately powered, minimum twelve-month randomized placebo-controlled trial in women dosed to the premenopausal physiological range, with a single pre-specified non-sexual primary endpoint such as a cognitive composite, bone density, lean mass and strength, or a validated wellbeing instrument, with sexual outcomes as secondary.

Did women in earlier, less industrialized eras have higher, or later-declining, testosterone than women today, such that the modern decline reflects something about modern life rather than pure biological aging?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The subsistence-population androgen literature that exists is overwhelmingly about men; no study directly compares testosterone concentrations in women of subsistence populations against a matched industrialized female sample. Where the neighboring hormones, estradiol and progesterone, have been compared this way, women in wealthier, industrialized settings run higher, not lower, which runs against the intuition behind this question.

What would test it: A single-method, single-laboratory mass spectrometry androgen panel measured in age-stratified women from two or more subsistence populations and a matched industrialized sample, assayed together.

Does a woman's testosterone level predict which women will respond to treatment, or does a low level carry no information at all about who will improve?

Studied and negative

What is known: A guideline states plainly that endogenous testosterone levels did not predict response to therapy in the trials that established short-term efficacy for low sexual desire; this is a treatment-response finding, not an untested question, and it is why a low testosterone level cannot function as a stand-alone diagnosis.

What would test it: A large population study of women across the transition, testosterone measured by mass spectrometry, with a systematic search for whether any symptom cluster has a syndromic association with the level, followed by a randomized trial in women selected on that cluster rather than on a level alone.

Sources

  1. 1.Global Consensus Position Statement on the Use of Testosterone Therapy for Women.Davis SR, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab 2019;104(10):4660-4666. · Systematic review or guideline
  2. 2.Accuracy of testosterone concentrations in compounded testosterone products.Grober ED, Garbens A, Bozovic A, Kulasingam V, Fanipour M, Diamandis EP. Accuracy of testosterone concentrations in compounded testosterone products. J Sex Med 2015;12(6):1381-1388. · Comparative or small study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides